Bruker Launches IMPACT HD Mass Spec Providing Exceptional Proteomic Results|
Tuesday, June 11, 2013
Bruker’s IMPACT HD sets a new scientific benchmark of well over 8000 protein identifications from whole-proteome analysis, a record-breaking insight into trace species in complex biological samples.
Roche Launches New Software Updates
Friday, June 07, 2013
New software tools for the LightCycler 96 and LightCycler Nano systems.
Dimerix HIT Assay to Understand Receptor Interactions Applied to Kinase Targets
Friday, May 31, 2013
Better understanding of receptor signalling, including effects arising from their functional interaction in heteromeric complexes, will progress drug development. Dimerix’s HIT assay is used to understand kinase heteromer signalling pathways.
Bio-Rad’s New SsoAdvanced™ Universal Supermixes Offer Superior Performance on any Real-Time PCR Instrument
Friday, May 31, 2013
The new SsoAdvanced universal supermixes include the SsoAdvanced™ universal SYBR® Green supermix and the SsoAdvanced universal probes supermix.
OGT Launches Ground-Breaking 58-Gene Tumour Profiling Service
Tuesday, May 28, 2013
This Technology Strategy Board-funded, government-backed assay performs significantly better than standard tests.
Definiens and ACD Introduce RNAscope SpotStudio™
Tuesday, May 21, 2013
Quantitative biomarker analysis advanced by alliance between ACD and Definiens, providers of breakthrough platform for in situ RNA biomarker detection and leading image analysis technology for digital pathology.
Bio-Rad Introduces New PrimePCR™ Mouse Assays and Panels — Industry’s Only Lab-Validated Real-Time PCR Primers
Friday, May 10, 2013
Bio-Rad’s PrimePCR assays are the industry’s only real-time PCR primers that have been experimentally validated to ensure performance.
Merck Millipore Launches MILLIPLEX® MAP Kits
Tuesday, May 07, 2013
Enables detection of multiple pluripotency markers in a single measurement.
Randox Licenses sPLA2 CVD Risk Test from Aterovax
Thursday, May 02, 2013
Partnership to develop Aterovax’s patented biomarker sPLA2 for the assessment of cardiovascular risk.